Rearranging genome with CRISPR
Using a new variation of gene-editing technology CRISPR, Stanford scientists were able to change the spatial organization of DNA in cell nuclei and show how physical relocation altered cell function.
Undiagnosed patients get answers
A network of doctors that aims to diagnose mystery diseases has named 31 newly identified conditions and diagnosed more than 100 previously unsolved cases, according new study.
Institute hosts inaugural symposium Nov. 16
The scientific community and public are invited to attend a daylong research symposium highlighting the work of researchers affiliated with the institute. Registration is free.
Swimming in polygons to avoid stronger light
A bioengineering lab has found that Euglena, a microscopic organism that has been studied for hundreds of years, swims in precise polygons when exposed to increased light intensity.
Celebrating visibility at LGBTQ+ Forum
A community event on Oct. 10 seeks to increase visibility and inclusion for sexual and gender minorities across Stanford Medicine.
Decision scientist seeks hepatitis B solutions
Mehlika Toy merged her interests in infectious diseases and mathematics to forge a career in decision science. She builds models to estimate the impact of clinical interventions to inform health policy.
Biohub funds new research efforts
Stanford faculty are helping to lead collaborative research teams funded by the Chan Zuckerberg Biohub.
Digital mosaic for Stanford Hospital
Thousands of drawings are being collected and will be assembled into a digital mosaic depicting the new hospital that will open in 2019.
Eight researchers awarded NIH grants
The Stanford scientists will receive $32 million over five years to fund explorations of cancer, the brain, the aging process, chromosomes and the development of cells.
Artandi to lead Stanford Cancer Institute
A cancer biologist, Artandi studies the role of telomerase in stem cells and cancer. He replaces outgoing director Beverly Mitchell.